Publikasi

This man with ALS is “the first power user” of a brain ...

Casey Harrell has had a set of electrodes embedded in his brain for almost three...

ZoBio Introduces DNA-Encoded Library Service for Explor...

ZoBio maintains that unlike transactional DEL screening approaches that focus so...

mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune ...

Moderna’s investigational mRNA flu vaccine generated broader, longer-lasting imm...

When Process Design Fails: 5 Common Planning Gaps That ...

In this GEN webinar, our speakers will examine five common planning gaps that ca...

Security System

SentriZone® by Crotega is a facility-based security system designed to help orga...

ChristianaCare Opens Neighborhood Hospital in Aston, Pa.

ChristianaCare opened the $50.9 million ChristianaCare Hospital, Aston, in early...

AI Predicts Gene Regulation for Drug Discovery Using Co...

Deep learning unveils how drugs affect the dynamics of key structures within the...

Board-Certified Physician Assistant Kieran Lombard, PA-...

Lombard is Eager to Provide Expert Medical Dermatology Services to Patients of A...

Dental technology’s biggest existential threats – and w...

Ashley Byrne reflects on 20 years of surviving the threats that were supposed to...

Children’s dental visits force half of parents to work ...

New data showing 46% of working parents have to work extra hours on evenings or ...

Patient groups praise Virginia PDAB veto

Patient advocates are praising Virginia Gov. Abigail Spanberger’s May 19 veto of...

The dentist’s darkest hours: is justice delayed still j...

We often talk about the dental team as a well-oiled machine, but behind every su...

Ensera and Argonaut partner to streamline supply for dr...

Delivering an integrated fill-finish and device assembly and packing collaborati...

Simcere and Stanford partner to develop IPF therapies

Under the deal, Simcere will provide funding for exploratory research on a first...

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC ...

This approval covers patients with ccRCC who are at intermediate-high or high ri...

Novartis India launches Pluvicto for PSMA-positive meta...

Radioligand therapy approved for eligible patients with PSMA-positive prostate ...